Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,856,938
-$475,228 QoQ
Shares Held
62,530
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.73%
of 13F equity value
Holder Rank
#289
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SPHERA FUNDS MANAGEMENT LTD. holds $104,911,681 across 12 Drug Manufacturers - General names. AZN ranks #2 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIIB |
Biogen Inc.
|
96,626 | $20,877,013 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
62,530 | $11,856,938 | |
| 3 | SNY |
Sanofi
|
269,515 | $11,497,509 | |
| 4 | LLY |
ELI LILLY & Co
|
8,040 | $9,643,418 | |
| 5 | NVS |
Novartis AG
|
50,000 | $7,836,000 | |
| 6 | ABBV |
AbbVie Inc.
|
30,256 | $7,613,619 | |
| 7 | MRK |
Merck & Co., Inc.
|
58,600 | $7,530,100 | |
| 8 | JNJ |
Johnson & Johnson
|
28,831 | $7,322,209 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,856,938 | 62,530 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,332,166 | 62,530 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||